Recent Advances on the s-Triazine Scaffold with Emphasis on Synthesis, Structure-Activity and Pharmacological Aspects: A Concise Review

被引：20

作者：

Majeed Ganai, Ab ^{[1
]}

Khan Pathan, Tabasum ^{[1
]}

Hampannavar, Girish A. ^{[1
,2
]}

Pawar, Chandrakant ^{[1
]}

Obakachi, Vincent A. ^{[1
]}

Kushwaha, Babita ^{[1
]}

Deshwar Kushwaha, Narva ^{[1
]}

Karpoormath, Rajshekhar ^{[1
]}

机构：

[1] Univ KwaZulu Natal Westville, Coll Hlth Sci, Dept Pharmaceut Chem, Discipline Pharmaceut Sci, ZA-4000 Durban, South Africa

[2] KLEUs Coll Pharm, Dept Pharmaceut Chem, Hubli 580031, Karnataka, India

来源：

CHEMISTRYSELECT | 2021年 / 6卷 / 07期

基金：

新加坡国家研究基金会;

关键词：

Anti-cancer; Anti-microbial; Anti-parasitic; SAR; s-Triazine; ONE-POT SYNTHESIS; SUBSTITUTED 1,3,5-TRIAZINES; STRAIGHTFORWARD SYNTHESIS; CATALYZED CYCLIZATION; BIOLOGICAL EVALUATION; DERIVATIVES; DESIGN; INHIBITORS; DISCOVERY; ALCOHOLS;

D O I：

10.1002/slct.202004591

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Triazine nuclei have occupied a propitious place in pharmaceutical chemistry due to their diverse biological behaviour. The marketed drugs such as Azacitidine, Melarsoprol, Altretamine and Almitrine display broad pharmacological activities like anti-cancer, anti-parasitic, anti-inflammatory, Respiratory stimulant and many more. Literature studies reveal that the 2, 4, and 6 substitution on s-triazine is important for varied biological activities. This diversity in pharmacological activities of triazine scaffold has fascinated the various researchers to further investigate its applications in the treatment of several diseases. This review is complementary to earlier reports and aims to review the work reported on various synthetic methods and biological activities of substituted s-triazine derivatives from 2016 to 2020 with a list of patents. The enriched structure-activity relationship may open the doors for further rational drug development of s-triazine containing analogues as good clinical candidates.

引用

收藏

页码：1616 / 1660

页数：45

相关论文

共 132 条

[1] The Journey of Thiazolidinediones as Modulators of PPARs for the Management of Diabetes: A Current Perspective [J].

Ahsan, Waquar .

CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (23) :2540-2554

[2] Synthesis, chemical and biological investigations of new Ru(III) and Se(IV) complexes containing 1,3,5-triazine chelating derivatives [J].

Al-Khodir, Fatima A. I. ;

Al-Warhi, Tarfah ;

Abumelha, Hana M. A. ;

Al-Issa, S. A. .

JOURNAL OF MOLECULAR STRUCTURE, 2019, 1179 :795-808

[3] Synthesis, characterization and evaluation of 1,3,5-triazine aminobenzoic acid derivatives for their antimicrobial activity [J].

Al-Zaydi, Khadijah M. ;

Khalil, Hosam H. ;

El-Faham, Ayman ;

Khattab, Sherine N. .

CHEMISTRY CENTRAL JOURNAL, 2017, 11

[4]

Alexander M.D., 2016, U.S. Patent, Patent No. [20160075720A1, 20160075720]

[5] Synthesis and computer-aided SAR studies for derivatives of phenoxyalkyl-1,3,5-triazine as the new potent ligands for serotonin receptors 5-HT6 [J].

Ali, Wesam ;

Wiecek, Malgorzata ;

Lazewska, Dorota ;

Kurczab, Rafal ;

Jastrzebska-Wiesek, Magdalena ;

Satala, Grzegorz ;

Kucwaj-Brysz, Katarzyna ;

Lubelska, Annamaria ;

Gluch-Lutwin, Monika ;

Mordyl, Barbara ;

Siwek, Agata ;

Nasim, Muhammad Jawad ;

Partyka, Anna ;

Sudol, Sylwia ;

Latacz, Gniewomir ;

Wesolowska, Anna ;

Kiec-Kononowicz, Katarzyna ;

Handzlik, Jadwiga .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 178 :740-751

[6]

[Anonymous], 2019, World Malaria Report

[7] Synthesis, antileishmanial activity and mechanism of action studies of novel β-carboline-1,3,5-triazine hybrids [J].

Barea, Paula ;

Barbosa, Valeria Aquilino ;

Bidoia, Danielle Lazarin ;

de Paula, Jessica Carreira ;

Stefanello, Talitha Fernandes ;

da Costa, Willian Ferreira ;

Nakamura, Celso Vataru ;

Sarragiotto, Maria Helena .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 150 :579-590

[8] 5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in Oncology [J].

Beaufils, Florent ;

Cmiljanovic, Natasa ;

Cmiljanovic, Vladimir ;

Bohnacker, Thomas ;

Melone, Anna ;

Marone, Romina ;

Jackson, Eileen ;

Zhang, Xuxiao ;

Sele, Alexander ;

Borsari, Chiara ;

Mestan, Jurgen ;

Hebeisen, Paul ;

Hillmann, Petra ;

Giese, Bernd ;

Zvelebil, Marketa ;

Fabbro, Doriano ;

Williams, Roger L. ;

Rageot, Denise ;

Wymann, Matthias P. .

JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (17) :7524-7538

[9]

Beck-Sickinger A.G., 2019, Patent, Patent No. [WO 2019/115614 A1, 2019115609]

[10] Structure-guided optimization of 4,6-substituted-1,3,5-triazin-2(1H)-ones as catalytic inhibitors of human DNA topoisomerase IIα [J].

Bergant, Kaja ;

Janezic, Matej ;

Valjavec, Katja ;

Sosic, Izidor ;

Pajk, Stane ;

Stampar, Martina ;

Zegura, Bojana ;

Gobec, Stanislav ;

Filipic, Metka ;

Perdih, Andrej .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 175 :330-348

← 1 2 3 4 5 6 7 8 9 10 →